BMRN BioMarin Pharmaceutical Inc. - Fundamental Analysis

NEUTRAL

BMRN Stock | Fundamental Analysis & Investment Insights

NASDAQ • Healthcare • Biotechnology

Current Price

$54.73

Analyst Target

$90.5

+65.4% Upside

52W High

$73.51

52W Low

$50.76

AI Analysis

Confidence Score

85%

Analysis Accuracy

BMRN shows neutral fundamentals based on available metrics. Mixed signals with both opportunities and risks present.

Key Strengths

Low debt with D/E ratio of 0.10

Key Risks

Limited historical data available for full assessment

Performance Snowflake

Multi-dimensional AI analysis across 5 key categories

Unlock AI-Powered Analysis

See Value, Future Performance, Past Performance, Financial Health & Dividend scores

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Unlock Price Charts

View historical price trends and analyst targets

Historical Performance Trends

Long-term financial metrics and growth patterns

Unlock Historical Data

View 3-year revenue, profit margins, and growth trends

Valuation Metrics

Key valuation ratios and pricing indicators

P/E, P/B, P/S, EV/EBITDA and more

Profitability, Growth & Financial Health

Detailed profit margins, ROE, debt ratios, and liquidity metrics

Unlock Detailed Metrics

View ROE, Operating Margin, Debt/Equity, Current Ratio and more

Sector Comparison & Peer Analysis

Compare BMRN against industry averages and similar companies

Unlock Sector Insights

See how BMRN compares to competitors and industry standards

Insider Trading & Analyst Ratings

Track insider transactions and Wall Street analyst recommendations

Unlock Insider Data

See recent insider buys/sells and analyst price targets

Back to All Stocks